home / stock / xgn / xgn articles

XGN Articles, Exagen Inc.

Stock Information
Company Name: Exagen Inc.
Stock Symbol: XGN
Market: NYSE
Website: exagen.com
Menu
XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board
Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...
Time to Play 5 Top-Ranked Stocks With Rising P/E? | Benzinga

Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because in...
Exagen Announces Campaign for Lupus Awareness Month | Benzinga

CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announc...

Exagen to Announce First Quarter 2024 Results on May 13, 2024 | Benzinga

CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, will release financial ...

Exagen Inc. Announces Changes to the Board of Directors | Benzinga

CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announc...
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum | Benzinga

CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announc...

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024 | Benzinga

CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, will release financial ...

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference | Benzinga

CARLSBAD, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announce...
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum | Benzinga

SAN DIEGO, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today a...

Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting | Benzinga

SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, announ...

Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference | Benzinga

SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today ...
Next 10